Hopp til innhold

Article

i4C - Strengthening International Collaboration for Capitalizing on Cost-Effective and Life-Saving Commodities

Published Updated

i4C is a consortium of researchers and partnering institutions seeking to increase access to life-saving medicines and health supplies for the world’s most vulnerable people.

i4c.jpg

i4C is a consortium of researchers and partnering institutions seeking to increase access to life-saving medicines and health supplies for the world’s most vulnerable people.


The i4C project brings together a consortium of researchers and partner institutions to evaluate policy interventions that aim to secure access to basic health commodities in low and middle income countries. The Norwegian Institute of Public Health (NIPH) is leading the project in collaboration with the Global Strategy Lab (GSL) at York University (Toronto, Canada), and is being supported by a Research Council of Norway four-year operating grant of 24.7 million kroner.

Improving access to health commodities

The project will evaluate eight international policy interventions directed at supporting the implementation of recommendations issued by the United Nations Commission on Life-Saving Commodities for Women and Children (UNCoLSC).  In particular, the project focus will be on improving access and strengthening innovation. The interdisciplinary project team will evaluate interventions such as free trade agreements, advocacy, international treaties, and new economic models for research and development.

i4C team

  • Principal Investigator: Trygve Ottersen, Director for the Division of Health Services at the Norwegian Institute of Public Health
  • Co-Principal Investigator: Steven J. Hoffmann, Director at the Global Strategy Lab, and Professor in the School of Health Policy and Management, York University, Toronto
  • NIPH Focal Point and contact person: Elizabeth Peacocke, Norwegian Institute of Public Health

Sub Project 1

Evaluating the impact of the East African Community free trade agreement and whether it improves access to medicines

Live Storehagen (NIPH)

Sub Project 2

The impact of emerging economies, such as the BRICS countries,* on access to medicines

Berit Sofie Hembre (NIPH)

Sub Project 3

Evidence, art and advocacy: assessing these strategies for promoting evidence informed decision making.

Steven Hoffman, Lathika Sritharan (GSL)

Sub Project 4

Evaluating how institutions with overlapping mandates partner and add value

Steven Hoffman (GSL), Trygve Ottersen (NIPH)

Sub Project 5

Considering the utility and cost/benefit of potential legal mechanisms and the effective scale up of life-saving commodities

Steven Hoffman, Lathika Sritharan (GSL)

Sub Projects 6&7

Prioritization models for global health R&D

Dimitrios Gouglas (NIPH)

Sub Project 8

Incentives to increase antibiotics innovation

Christine Årdal (NIPH)

 * BRICS: Brazil, Russia, India, China, South Africa